These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28875225)

  • 1. Methodological quality evaluation of systematic reviews or meta-analyses on ERCC1 in non-small cell lung cancer: a systematic review.
    Tao H; Zhang Y; Li Q; Chen J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2245-2256. PubMed ID: 28875225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological quality evaluation of systematic reviews or meta-analysis of trastuzumab-based therapy for breast cancer: A systematic review.
    Wei H; Zhang YJ; Yu T; Yan XY; Jiang Q
    Medicine (Baltimore); 2021 Jan; 100(4):e24389. PubMed ID: 33530234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.
    Wei SZ; Zhan P; Shi MQ; Shi Y; Qian Q; Yu LK; Song Y
    Med Oncol; 2011 Mar; 28(1):315-21. PubMed ID: 20143185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Overview of systematic reviews and Meta-analysis of Aidi Injection combined with chemotherapy in treatment of non-small cell lung cancer].
    Gui YR; Fan BJ; Li JL; Wang S; Dong J; Hou W
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(14):3923-3932. PubMed ID: 35850851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
    Xu TP; Shen H; Liu LX; Shu YQ
    Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive effect of compound Kushen Injection to chemotherapy for non-small cell lung cancer: An evidence map and overview of systematic reviews.
    Yu ZY; Peng RY; Han M; Grant S; Yang GY; Liu JP; Cao HJ
    J Ethnopharmacol; 2021 Dec; 281():114538. PubMed ID: 34418510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations.
    Hubner RA; Riley RD; Billingham LJ; Popat S
    PLoS One; 2011; 6(10):e25164. PubMed ID: 22022380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analytic review of ERCC1/MDR1 polymorphism and chemosensitivity to platinum in patients with advanced non-small cell lung cancer.
    Wei HB; Hu J; Shang LH; Zhang YY; Lu FF; Wei M; Yu Y
    Chin Med J (Engl); 2012 Aug; 125(16):2902-7. PubMed ID: 22932088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of Shenqi Fuzheng injection combined with chemotherapy for cancer: An overview of systematic reviews.
    Chen G; Lu J; Li B; Zhao M; Liu D; Yang Z; Liu F
    Phytomedicine; 2024 Mar; 125():155293. PubMed ID: 38295658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abstract analysis method facilitates filtering low-methodological quality and high-bias risk systematic reviews on psoriasis interventions.
    Gómez-García F; Ruano J; Aguilar-Luque M; Alcalde-Mellado P; Gay-Mimbrera J; Hernández-Romero JL; Sanz-Cabanillas JL; Maestre-López B; González-Padilla M; Carmona-Fernández PJ; García-Nieto AV; Isla-Tejera B
    BMC Med Res Methodol; 2017 Dec; 17(1):180. PubMed ID: 29284417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
    Booton R; Ward T; Ashcroft L; Morris J; Heighway J; Thatcher N
    J Thorac Oncol; 2007 Oct; 2(10):902-6. PubMed ID: 17909351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Critical Overview of Systematic Reviews of Chemotherapy for Advanced and Locally Advanced Pancreatic Cancer using both AMSTAR2 and ROBIS as Quality Assessment Tools.
    Dang A; Chidirala S; Veeranki P; Vallish BN
    Rev Recent Clin Trials; 2021; 16(2):180-192. PubMed ID: 32875987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and Safety of Acupuncture for Migraine: An Overview of Systematic Reviews.
    Li YX; Xiao XL; Zhong DL; Luo LJ; Yang H; Zhou J; He MX; Shi LH; Li J; Zheng H; Jin RJ
    Pain Res Manag; 2020; 2020():3825617. PubMed ID: 32269669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer--a pilot study.
    Krawczyk P; Wojas-Krawczyk K; Mlak R; Kucharczyk T; Biernacka B; Milanowski J
    Folia Histochem Cytobiol; 2012 Apr; 50(1):80-6. PubMed ID: 22532140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
    Vilmar A; Sørensen JB
    Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems of variable biomarker evaluation in stratified medicine research--A case study of ERCC1 in non-small-cell lung cancer.
    Malottki K; Popat S; Deeks JJ; Riley RD; Nicholson AG; Billingham L
    Lung Cancer; 2016 Feb; 92():1-7. PubMed ID: 26775588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis.
    Chen S; Zhang J; Wang R; Luo X; Chen H
    Lung Cancer; 2010 Oct; 70(1):63-70. PubMed ID: 20541281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese patent medicine Kanglaite injection for non-small-cell lung cancer: An overview of systematic reviews.
    Lu T; Yu J; Gao R; Wang J; Wang H; Wang X; Xu B; Cao L; Wu J; Ni B; Li S; Li J
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115814. PubMed ID: 36240975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological quality and risk-of-bias assessments in systematic reviews of treatments for peri-implantitis.
    Hasuike A; Ueno D; Nagashima H; Kubota T; Tsukune N; Watanabe N; Sato S
    J Periodontal Res; 2019 Aug; 54(4):374-387. PubMed ID: 30671962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
    Kalikaki A; Voutsina A; Koutsopoulos A; Papadaki C; Sfakianaki M; Yachnakis E; Xyrafas A; Kotsakis A; Agelaki S; Souglakos J; Mavroudis D; Georgoulias V
    Cancer Invest; 2015 Apr; 33(4):107-13. PubMed ID: 25647444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.